日本産科婦人科内視鏡学会雑誌
Online ISSN : 1884-5746
Print ISSN : 1884-9938
原著論文
卵巣奇形腫における悪性転化の術前予測についての検討
牧原 夏子蝦名 康彦山崎 友維生橋 義之松岡 正造前田 哲雄川上 史山田 秀人
著者情報
ジャーナル フリー

2014 年 30 巻 1 号 p. 112-116

詳細
抄録
Background: Preoperative factors were retrospectively analyzed to distinguish malignant transformation (MT) in mature cystic teratoma (MCT) of the ovary.
Methods: Subjects were 73 patients with MCT and 4 patients with MT who underwent surgery from January 2010 to March 2013.
Results: Patients with MT had a median age of 68.5 years, significantly older than patients with MCT who had a median age of 34.0 years. All of the patients with MT (100%) had a tumor 10 cm across or larger while 12 (16%) patients with MCT did. Most patients with MT (75.0%) had an squamous cell carcinoma(SCC) antigen level of 2.5 ng/mL or higher while few (6.7%) patients with MCT did. Most patients with MT (75.0%) had a Carcinoembryonic antigen (CEA) level at or above the cutoff (5.0 mg/mL) significantly higher than the few (3.2%) patients with MCT. In a pelvic MRI, most patients with MT (75%) had a tumor with contrast-enhanced solid portions significantly more than the few (9.5%) patients with MCT.
had a tumor with contrast-enhanced solid part.
Discussion: Most patients with MT were 60 years of age or older and had a tumor 10 cm or larger, a serum SCC antigen level of 2.5 ng/mL or greater, a serum CEA level of 5.0 mg/mL or greater, and a tumor with solid portions that were contrast-enhanced. Laparoscopyic findings should be considered in cases where the aforementioned factors are not present.
著者関連情報
© 2014 日本産科婦人科内視鏡学会
前の記事 次の記事
feedback
Top